What Are Myoclonic Jerks? Causes, Types, and Treatment

Myoclonic jerks are sudden, brief, involuntary muscle contractions that can look like a twitch, a jolt, or a quick “shock” to a particular body part. Nearly everyone has experienced one: the sharp full-body jerk that strikes just as you’re falling asleep is the most familiar example. But myoclonus (the medical term for these jerks) spans a wide spectrum, from completely harmless sleep-related twitches to signs of serious neurological disease. The type, the cause, and the appropriate treatment differ enormously depending on where the jerk originates in the nervous system and what is driving it.

The Harmless Kind Almost Everyone Has

The myoclonic jerks people encounter most often are so-called hypnic jerks, also known as sleep starts or hypnagogic jerks. These occur during the transition between wakefulness and sleep and can happen in healthy individuals of any age.¹ They are thought to arise from sudden bursts of activity in the brainstem reticular formation, a region that becomes unstable during the shift from waking to sleeping. The jerk itself may last only a fraction of a second, but it often comes with a racing heartbeat, a sharp intake of breath, and the sensation of falling or receiving an electric shock.

Up to about 70% of adults experience hypnic jerks at some point in their lives. They tend to become more frequent and more intense under certain conditions: fatigue, emotional stress, sleep deprivation, vigorous exercise close to bedtime, and stimulants like caffeine and nicotine can all ramp them up.¹ Hiccups are another form of physiological myoclonus, involving involuntary, spasmodic contractions of the diaphragm and other inspiratory muscles.² Neither hypnic jerks nor hiccups require treatment in otherwise healthy people, though persistent or severe hypnic jerks that disrupt sleep deserve a conversation with a doctor, particularly if they coincide with starting a new medication.

When Myoclonus Is Part of Epilepsy

Myoclonic jerks are a defining seizure type in several epilepsy syndromes, and distinguishing epileptic myoclonus from the harmless kind is one of the most important clinical tasks. In epileptic myoclonus, the jerks are driven by abnormal synchronized electrical discharges in the brain’s cortex that show up on an EEG.

Juvenile myoclonic epilepsy (JME) is among the most common forms. In a study of 60 patients, the average age when myoclonic jerks first appeared was around 14 years, and all patients had myoclonic jerks, while roughly 87% also experienced generalized tonic-clonic (grand mal) seizures.³ A striking finding in that study was the diagnostic delay: on average, more than five years passed between the onset of myoclonic jerks and a correct JME diagnosis, and only 10% of referring physicians initially identified it correctly. Sleep deprivation was the most common trigger, reported by 80% of patients, followed by fatigue at about two-thirds.³

JME is generally treatable. Research into what predicts a good outcome has found that patients whose seizures began as myoclonic jerks (rather than tonic-clonic seizures) and who had strong academic performance were far more likely to achieve seizure freedom, while a high initial frequency of generalized tonic-clonic seizures and failure of two or more appropriate medications were associated with poor outcomes.⁴ JME typically requires lifelong medication, but many people live normal lives once their seizures are controlled.

Progressive Myoclonus Epilepsies

A more severe category is the progressive myoclonus epilepsies (PMEs), a group of rare genetic disorders in which myoclonus worsens over time and is accompanied by cognitive decline and other neurological problems. Two classic forms are Unverricht-Lundborg disease (ULD) and Lafora disease. Genetic studies mapped the ULD gene (EPM1) to chromosome 21, and further analysis confirmed that the Lafora disease gene lies at a different location, establishing these as genetically distinct conditions despite their clinical overlap.⁵

ULD is caused by mutations in the cystatin B gene. Research has revealed that the disease shares certain pathological processes with Lafora disease and the neuronal ceroid lipofuscinoses (another PME group), including overactive inflammatory cells in the brain, abnormal synaptic remodeling, neuronal hyperexcitability, and problems with the cell’s waste-disposal and energy-production systems.⁶ These shared mechanisms are why researchers are hopeful that treatments targeting one PME could eventually benefit others, though no cure exists for any of them yet.

Hereditary Myoclonus-Dystonia

Not all hereditary myoclonus involves epilepsy. Myoclonus-dystonia syndrome (MDS) is a rare autosomal-dominant movement disorder caused by mutations in the SGCE gene. It typically begins in childhood or early adolescence and is characterized by brief, lightning-fast myoclonic jerks that most often affect the neck, trunk, and upper limbs, with less involvement of the legs.⁷ Around half of affected individuals also develop dystonia, often appearing as abnormal neck postures or difficulty writing.

One of the most distinctive features of SGCE myoclonus-dystonia is alcohol responsiveness: most affected adults report a dramatic reduction in myoclonus after drinking alcohol.⁷ This is diagnostically useful but creates an obvious clinical problem, as the condition is also associated with higher rates of alcohol misuse, obsessive-compulsive disorder, and anxiety.⁷ Symptom onset almost always occurs before age 20, though it can range from infancy to late adulthood. Diagnosis has improved with genetic testing; whole-exome sequencing can now identify novel SGCE variants even in patients whose initial workups were inconclusive.⁸

Drug-Induced Myoclonus

Medications are one of the more common and underrecognized causes of myoclonus. Many cases of drug-induced myoclonus are transient and happen alongside a broader picture of confusion or metabolic disruption during illness.⁹ A systematic review catalogued the medications with the strongest evidence for causing myoclonus. The list is long and spans many drug classes:

Opioids: fentanyl and morphine, especially at higher doses or with kidney impairment
Antidepressants: several SSRIs (citalopram, escitalopram, paroxetine, sertraline) and the tricyclic antidepressant amitriptyline
Antiseizure drugs: paradoxically, medications meant to treat seizures, including carbamazepine, phenytoin, gabapentin, pregabalin, and valproate, can themselves provoke myoclonus
Antipsychotics: clozapine and quetiapine
Antibiotics: certain cephalosporins and fluoroquinolones
Other agents: lithium, amantadine, bismuth salts, and the anesthetic etomidate

All of these carried what the review classified as the highest level of evidence for a causal link.⁹ Etomidate, a commonly used intravenous anesthetic, has been particularly well studied. Research in animal models has shown that etomidate-induced myoclonus originates in the brain’s neocortex and involves accumulation of the excitatory neurotransmitter glutamate along with downstream changes in receptor activity.¹⁰ The practical takeaway: if you develop new jerking movements while on a medication, drug-induced myoclonus should be considered. In most cases, the myoclonus resolves when the offending drug is reduced or stopped.

Post-Hypoxic Myoclonus

When the brain is deprived of oxygen, as during cardiac arrest, near-drowning, or severe respiratory failure, myoclonus can develop afterward. Clinicians draw a critical distinction between two forms. Myoclonus status epilepticus (MSE) appears while the patient is still comatose and generally signals a poor prognosis, especially when the jerks are generalized across the body.¹¹ Lance-Adams syndrome (LAS), on the other hand, is a form of chronic post-hypoxic myoclonus that emerges after the patient has regained consciousness and carries a far better prognosis.¹²

Even so, LAS often remains chronic and disabling, with action myoclonus, meaning jerks triggered by voluntary movement, making everyday tasks difficult.¹³ Differentiating MSE from LAS is one of the more consequential diagnostic decisions in neurology, because the prognosis and treatment approach diverge sharply.

Myoclonus in Neurodegenerative Disease

Myoclonic jerks can also be a feature of neurodegenerative conditions, and in some cases they are an important early clue. Creutzfeldt-Jakob disease (CJD), a rapidly progressive and invariably fatal prion disease, has myoclonus as one of its characteristic signs, alongside rapidly progressive dementia, visual or balance problems, and distinctive EEG and MRI findings.¹⁴ The combination of dementia plus myoclonus in an older adult should prompt consideration of CJD, though the condition remains rare. Myoclonus also occurs in some patients with Alzheimer’s disease, Lewy body dementia, and other degenerative conditions, though it tends to appear later in the disease course and is usually less prominent than in CJD.

How Myoclonus Is Distinguished from Similar Movements

Several other involuntary movements can mimic myoclonus, and telling them apart matters for treatment. Tics, for instance, can look like sudden jerks, but a person with a tic usually feels an urge to move beforehand and can temporarily suppress the tic through effort, followed by a sense of relief. Myoclonus, by contrast, cannot be voluntarily suppressed.¹⁵

Rhythmic myoclonus can be confused with tremor, but myoclonus tends to have a square-wave quality, with a clear gap between each jerk, while tremor is smoother and more sinusoidal, like shaking. Myoclonus is typically slower than the common tremor types, often persists during sleep, and is not much affected by voluntary movement, whereas many tremors change with posture or action.¹⁵ Chorea, which produces a continuous flow of random, dance-like movements, can also look like myoclonus when the jerks are fast and multifocal, but chorea’s movements are more flowing and continuous rather than the staccato quality of myoclonic jerks.¹⁵

Functional (Psychogenic) Myoclonus

Not all myoclonus has a structural or chemical cause in the nervous system. Functional myoclonus, previously called psychogenic myoclonus, is a real and often debilitating condition in which the brain produces jerking movements without underlying epilepsy, degeneration, or metabolic derangement. The clinical presentation can be remarkably varied, mimicking virtually any form of organic myoclonus, whether cortical, subcortical, or spinal in origin. The jerks can be focal or widespread, rhythmic or random, spontaneous or triggered by stimuli.¹⁶

Diagnosis relies on neurophysiological testing. One key finding is that in functional myoclonus, the delay between a stimulus and the resulting jerk is too long and too variable compared to genuine reflex myoclonus. Spontaneous functional jerks may also be preceded by a slow brain-wave buildup (a pre-movement potential) detectable by specialized EEG averaging, suggesting that the brain is “preparing” for a movement it then produces involuntarily.¹⁶ Treatment for functional myoclonus is fundamentally different from treatment for organic myoclonus: it centers on specialized physical therapy, cognitive behavioral therapy, and education rather than anti-seizure drugs.

What Is Happening in the Brain

Myoclonus can originate at several levels of the nervous system, and pinpointing the source determines treatment. Cortical myoclonus arises from the brain’s outer layer and is the most common form seen in clinical practice. Subcortical myoclonus originates deeper in the brain. Brainstem myoclonus comes from the lower brain structures, and spinal myoclonus arises from the spinal cord itself.

At the neurotransmitter level, the picture is complicated. Serotonin receptors (particularly the 5-HT1A and 5-HT2 subtypes) are implicated in certain forms of myoclonus. GABA, the brain’s main inhibitory neurotransmitter, has a paradoxical relationship with myoclonus: blocking GABA receptors or GABA production tends to cause seizures, but giving GABA-boosting drugs can actually provoke myoclonus in some circumstances.¹⁷ Whether stimulating GABA receptors helps or worsens myoclonus depends on which specific receptors are involved and the state of the system at the time. This complexity is one reason myoclonus can be so difficult to treat: a medication that helps one type may worsen another.

How Myoclonus Is Diagnosed

A standard EEG is the usual starting point, looking for the abnormal electrical discharges that characterize epileptic myoclonus. In JME, for instance, EEGs often show a characteristic pattern of generalized polyspike-and-wave discharges.³ But EEGs are not always revealing. When standard scalp EEG looks normal despite clinically obvious myoclonus, a technique called jerk-locked back-averaging can be useful, where the EEG is time-locked to each myoclonic jerk (captured on simultaneous muscle recordings) and the signals are averaged together to reveal subtle cortical discharges that would otherwise be invisible.¹⁸

Beyond EEG, the diagnostic workup often includes blood tests for metabolic abnormalities, MRI of the brain, and sometimes genetic testing. For hereditary conditions like SGCE myoclonus-dystonia, whole-exome sequencing has become increasingly important.⁸ When prion disease is suspected, CSF analysis (looking for the 14-3-3 protein) and characteristic MRI patterns help confirm the diagnosis.¹⁴

Treatment Options by Type

Because myoclonus is not a single disease but a symptom with many causes, there is no universal treatment. When myoclonus is caused by a drug, the primary treatment is removing or adjusting the offending medication. When it is part of an epilepsy syndrome, seizure-control medications form the backbone of therapy. When a metabolic problem is driving it, correcting the underlying abnormality is the priority.

For cortical myoclonus, which is the most common form seen in clinical settings, three medications are the mainstay: levetiracetam, valproic acid, and clonazepam.¹⁹ Levetiracetam is often recommended as first-line, and clinical studies have shown that it can reduce both the severity of myoclonic jerks and the abnormally large brain responses to sensory stimulation that accompany cortical myoclonus.²⁰ Valproic acid is well established for myoclonic epilepsy syndromes like JME, where it often controls both the myoclonus and the associated tonic-clonic seizures.

Treatment differs when the myoclonus originates from deeper structures. For subcortical and brainstem myoclonus, clonazepam is generally considered first-line, though levetiracetam and valproic acid can also be tried. In cases that do not respond to these standard agents, less commonly used drugs like L-5-hydroxytryptophan (a serotonin precursor) and sodium oxybate are sometimes employed.²¹ Spinal myoclonus is a special situation: it generally does not respond to anti-seizure drugs, and clonazepam is the go-to first option. When spinal myoclonus is focal, meaning it affects a limited area, botulinum toxin injections can be useful.²¹

Myoclonus in Animals

Myoclonus is not unique to humans. In veterinary neurology, one of the better-known causes is canine distemper, a viral disease that can damage the nervous system and leave dogs with persistent myoclonic jerking even after the acute infection resolves. A study evaluating vitamin D3 supplementation in dogs with distemper-associated myoclonus found no change in the myoclonic movements with the doses and treatment duration used, underscoring how difficult this type of myoclonus is to treat once established.²² The condition tends to be permanent in dogs, reflecting irreversible damage to the neurons involved. Pet owners sometimes mistake these persistent rhythmic jerks for seizures, but they represent a different phenomenon: localized, repetitive contractions of specific muscle groups rather than the widespread, coordinated electrical storms of a true seizure.

1
PubMed Central. Hypnic Jerks, Major Depressive Disorder, and Antidepressant Use: A Possible Relationship
2
PubMed Central. Hiccup-like Contractions in Mechanically Ventilated Patients: Individualized Treatment Guided by Transpulmonary Pressure
3
PubMed Central. Clinical and EEG characteristics of Juvenile Myoclonic Epilepsy
4
PubMed. Seizure freedom in pediatric juvenile myoclonic epilepsy: The roles of cognition, chronodependency, and EEG
5
PubMed. Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora’s diseases
6
Exploration of Neuroscience. Molecular and cellular processes underlying Unverricht-Lundborg disease—prospects for early interventions and a cure
7
PubMed. SGCE Myoclonus-Dystonia
8
PubMed Central. Novel SGCE Mutation in a Patient With Myoclonus-Dystonia: A Case Report
9
PubMed Central. Drug-Induced Myoclonus: A Systematic Review
10
PubMed. Etomidate-Induced Myoclonus in Sprague-Dawley Rats Involves Neocortical Glutamate Accumulation and N-Methyl-d-Aspartate Receptor Activity
11
Clinical Neurophysiology Practice. Post-hypoxic myoclonus: Differentiating benign and malignant etiologies in diagnosis and prognosis
12
PubMed Central. Lance–Adams syndrome or chronic post-hypoxic myoclonus in adults: a systematic literature review
13
PubMed Central. Lance-Adams Syndrome: An Updated Review of a Rare Post-Hypoxic Complication
14
Bangladesh Critical Care Journal. An elderly lady with dementia and myoclonus : Think of Sporadic Creutzfeldt Jakob Disease
15
Journal of Movement Disorders. Electrophysiologic Assessments of Involuntary Movements: Tremor and Myoclonus
16
PubMed. Clinical neurophysiology of psychogenic movement disorders: how to diagnose psychogenic tremor and myoclonus
17
PubMed. Myoclonus: analysis of monoamine, GABA, and other systems
18
PubMed Central. The utility of Jerk-locked back averaging technique in diagnosis of generalized myoclonic epilepsy with normal scalp EEG
19
PubMed Central. Treatment of myoclonus
20
PubMed. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study
21
PubMed. Myoclonus: Pathophysiology and Treatment Options
22
Research, Society and Development. Clinical and hematological evaluation in dogs with myoclonus derived from canine distemper supplemented with vitamin D3